Information Provided By:
Fly News Breaks for July 8, 2015
LMNX, SIEGY, RHHBY, ILMN, HOLX, BDX, A, AFFX, ABT, ENZ
Jul 8, 2015 | 09:26 EDT
Enzo Biochem (ENZ) announced that the U.S. District Court for the District of Delaware has issued a claim construction order governing ten ongoing patent litigations brought by Enzo against eleven companies regarding Enzo’s U.S. Patent Nos. 6,992,180; 7,064,197; and 8,097,405. In its claim construction ruling, the Court adopted Enzo’s proposed constructions for the majority of the disputed claim terms. The court also rejected the defendants’ argument that Enzo’s U.S Patent No. 6,992,180 is invalid for indefiniteness. One or more of the patents addressed in the ruling is asserted against Abbott Labs (ABT), Affymetrix (AFFX), Agilent (A), Becton Dickinson (BDX), Gen-Probe, Hologic (HOLX), Illumina (ILMN), Life Technologies, Roche (RHHBY) and Siemens (SIEGY), and their related entities. A settlement involving the remaining defendant, Luminex (LMNX), was announced earlier this week. In a patent claim construction hearing, also called a Markman hearing, the Judge is asked to issue rulings interpreting the language of the patents at issue in the case. Markman hearings are considered an important event in a patent lawsuit.
News For ENZ;ABT;AFFX;A;BDX;HOLX;ILMN;RHHBY;SIEGY;LMNX From the Last 2 Days
SIEGY
Mar 26, 2024 | 08:06 EDT
Orchestra BioMed announced the appointment of David Pacitti to its Board of Directors, effective as of March 26, 2024. Mr. Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers.